4//SEC Filing
Zhang Xiaoyan Michelle 4
Accession 0000899243-22-001806
CIK 0001835579other
Filed
Jan 11, 7:00 PM ET
Accepted
Jan 12, 7:25 PM ET
Size
14.0 KB
Accession
0000899243-22-001806
Insider Transaction Report
Form 4
Zhang Xiaoyan Michelle
Chief Scientific Officer
Transactions
- Sale
Common Stock
2022-01-10$12.00/sh−36$432→ 44,475 total - Exercise/Conversion
Common Stock
2022-01-11$2.15/sh+964$2,069→ 45,439 total - Exercise/Conversion
Common Stock
2022-01-10$2.15/sh+36$77→ 44,511 total - Sale
Common Stock
2022-01-11$12.00/sh−964$11,568→ 44,475 total - Exercise/Conversion
Stock Option (Right to Buy)
2022-01-10−36→ 25,437 totalExercise: $2.15Exp: 2028-12-17→ Common Stock (36 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2022-01-11−964→ 24,473 totalExercise: $2.15Exp: 2028-12-17→ Common Stock (964 underlying)
Footnotes (2)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 22, 2021.
- [F2]25% of the shares subject to this option vested and became exercisable on December 14, 2018, with the remainder vesting in 36 substantially equal monthly installments thereafter.
Documents
Issuer
Ikena Oncology, Inc.
CIK 0001835579
Entity typeother
Related Parties
1- filerCIK 0001895321
Filing Metadata
- Form type
- 4
- Filed
- Jan 11, 7:00 PM ET
- Accepted
- Jan 12, 7:25 PM ET
- Size
- 14.0 KB